Liver X receptor-α mediates cholesterol efflux in glomerular mesangial cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Role of LXRs in control of lipogenesis
2000 • 1,623 citations
Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα
1998 • 1,408 citations
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
2001 • 1,287 citations
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
2001 • 1,134 citations
LXR, a nuclear receptor that defines a distinct retinoid response pathway.
1995 • 1,089 citations
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
1982 • 1,021 citations
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
2002 • 913 citations
Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
2000 • 846 citations
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
1998 • 667 citations
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
2001 • 643 citations
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
1988 • 413 citations
Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice
2001 • 396 citations
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
1996 • 378 citations
Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease
2004 • 269 citations
Putative Metabolic Effects of the Liver X Receptor (LXR)
2004 • 249 citations
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
1997 • 221 citations
Constitutive Activation of Peroxisome Proliferator-activated Receptor-γ Suppresses Pro-inflammatory Adhesion Molecules in Human Vascular Endothelial Cells
2002 • 211 citations
Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
2000 • 209 citations
Lipids and Progressive Glomerulosclerosis
1988 • 207 citations
Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats
1998 • 204 citations
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
2001 • 190 citations
Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats
2000 • 189 citations
Accumulation of Foam Cells in Liver X Receptor-Deficient Mice
2002 • 185 citations
Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
1991 • 183 citations
Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage
2003 • 152 citations
Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease
2004 • 133 citations
PPAR Agonists Protect Mesangial Cells from Interleukin 1β-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway
2003 • 113 citations
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation11See Editorial by van Zonneveld and Rabelink, p. 2037
2001 • 108 citations
The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility
2004 • 102 citations
LXRs: new therapeutic targets in atherosclerosis?
2003 • 101 citations
Cholesterol uptake in adrenal and gonadal tissues the SR BI and selective pathway connection
2003 • 99 citations
Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion
2000 • 98 citations
Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity
2003 • 92 citations
LXRα functions as a cAMP-responsive transcriptional regulator of gene expression
2000 • 83 citations
Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature
2001 • 75 citations
Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home
2002 • 73 citations
Modulation of PPARγ activity with pharmaceutical agents: Treatment of insulin resistance and atherosclerosis
2003 • 63 citations
Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial Cells
2002 • 56 citations
Glomerular structures and lipids in progressive renal disease.
1989 • 49 citations
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
2003 • 49 citations
Inflammation modifies lipid-mediated renal injury
2002 • 41 citations
Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1
2003 • 38 citations
Relationship between Hyperlipidemia, Lipid Mediators, and Progressive Glomerulosclerosis in the Nephrotic Syndrome
1993 • 35 citations
Cloning and expression of the rabbit prostaglandin EP2 receptor.
2002 • 23 citations